factors probably disclose only these malformations. OFC from 1 to 10 have been accredited in CL+-P several loci. The first locus, OFC1, has been charted to chromosome 6p24. Other CL+-P loci have been charted to 2p13 (OFC2), 19q13.2 (OFC3) and 4q (OFC4). OFC5-8 are acknowledged by mutations in the MSX1, IRF6, PVRL1, and TP73L gene. OFC9 maps to 13q33.1-q34, whereas OFC10 is related with the SUMO1 gene. In cleft inception, MTHFR, TGF-b3, and RARA play a role in additionally. At present TBX22 is also identified in CPI. On chromosome 6, inside the region 6p24.3, studied using YACs proved the existence of a major dominant gene referred to as OFC1, placed closely to HGP22 and AP2 genes involved in the morphogenesis of human face. In some populations the association of CL+-P with mutations of the TGFA gene located on chromosome 2p13 (locus OFC2) was strongly proved 3 . A similar study about gene involvement in CL+-P from recent data and conducted a search of the MEDLINE database (Entrez Pub Med) from 1986 to 2010. They established that several genes responsible for syndromic CL+-P. Three of them are T-boxtranscription factor-22 (TBX22), poliovirus receptor-like-1 (PVRL1), and interferon regulatory factor-6 (IRF6)-were responsible for causing cleft palate X-linked (CPX), CL+-P ectodermal dysplasia syndrome, Van der Woude and popliteal pterygium syndromes, correspondingly they were also implicated in non syndromic CL+-P. An investigation of the role of maternal folate intake was done by Chevrier et al. 6 . Their assessment was about diet or vitamin supplementation and found CL+-P and CPI was on risk because of methylentetrahydrofolate reductase gene (MTHFR) polymorphism and their interaction. 262 case-parent triads from a population-based study of OFC in Norway were selected and analyzed TGFA, TGFB3, and MSX1 which were responsible for OFC or not.. 174 triads of CL+/-P cases and 88 triads of CPI cases were taken for examination. A little participation was observed of any of these genes with CL+-P and the robust association was a 1.7-fold risk with two copies of the TGFB3-CA variant. Among CPO cases, there was a 3-fold risk with two copies of the TGFA TaqI A2 allele, and no increase with one copy. Among children homozygous for the MSX1-CA A4 allele, TGFA genotype was even stronger raising the possibility of interface between these two genes 7 . TBX22 was scrutinized with a large number of CL+-P patients with no pre-selection for legacy or ankyloglossia which was a familiar feature of CPX. Mutations in CPX families and united phenotype/genotype analysis of the familial cases have been observed by Marcano et al. 8 . Cleft palate and ankyloglossia together were commonly shown by males but CPO and/ or ankyloglossia were shown by families which indicating that defects are distinct parts of the phenotypic spectrum. It can be apprised that for cleft palate, a significant risk factor is TBX22. Distinctive mutation is occurred in CPX by T-boxcontaining transcription factor TBX22 9 . According to their explanation, in early human development, TBX22 is noticed in the palatal shelves and is highest prior to elevation to a horizontal position above the tongue. In case of CPX patients mRNA was also identified in the frenulum area of the base of the tongue which is communicated with ankyglossia. However, they completed their study with the CPX phenotype, TBX22 is completely reliable gene factor.
In a study also executed DNA marker linkage of a large British Columbia (B.C.) Native family with CPX found DXYS12 and DXS17 was responsible gene for CPX which were located to theXq21.3-q22 region 10 . TGFB3 rs2300607 (IVSI+ 5321) gene is associated with non syndromic CL+-P and may be a good screening marker for non syndromic CL+-P 11 . In a study assessing various factors affecting degree of malocclusion as favorable and unfavorable dental arch relationship of Japanese unilateral CLP patients revealed, clefts patients tend to develop unfavorable dental arch relationship not only as an effect of primary surgery but also due to a genetic influence of family history of class III 12 .
The results of literature survey of involvement of gene in CLP patients are shown in Table 1 . In all-purpose, the genetic cause of CL+-P is still controversial because of genetic intricacy of clefting. Consequences from earlier studies support the presence of heterogeneity among populations and the presence of multiple genes concerned in the etiology of CL+-P. Furthermore, current scientific advances in gene manipulation promises a motivating time ahead for CL+-P research.
